Anne K Wouters

5PUBLICATIONS
23CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 19, 2025
TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.

Rosa A van Amerongen, Sander Tuit, Dennis F G Remst

|Aug 11, 2023
Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma.

Tassilo L A Wachsmann, Miranda H Meeuwsen, Dennis F G Remst

|Apr 05, 2022
Cutting Edge: Unconventional CD8+ T Cell Recognition of a Naturally Occurring HLA-A*02:01-Restricted 20mer Epitope.

Miranda H Meeuwsen, Anne K Wouters, Renate S Hagedoorn

|Feb 07, 2022
Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure.

Tassilo L A Wachsmann, Anne K Wouters, Dennis F G Remst

Pageof 1